This hypothesis could be confirmed for TYK2, a very striking example for which 7/18 (38%) T-ALL cell lines contain novel TYK2 sequence variants as opposed to only 2/93 (2%) T-ALL patients. Here, TYK2 is linked to acute lymphoblastic leukemia.